196 related articles for article (PubMed ID: 17652170)
21. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
[TBL] [Abstract][Full Text] [Related]
22. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
[TBL] [Abstract][Full Text] [Related]
23. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
[TBL] [Abstract][Full Text] [Related]
24. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B
Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794
[TBL] [Abstract][Full Text] [Related]
25. Maternal leukemia inhibitory factor (LIF) promotes fetal neurogenesis via a LIF-ACTH-LIF signaling relay pathway.
Simamura E; Shimada H; Higashi N; Uchishiba M; Otani H; Hatta T
Endocrinology; 2010 Apr; 151(4):1853-62. PubMed ID: 20160138
[TBL] [Abstract][Full Text] [Related]
26. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.
White UA; Stewart WC; Stephens JM
Obesity (Silver Spring); 2011 May; 19(5):903-10. PubMed ID: 21164505
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
28. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
29. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
30. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
Hui W; Bell M; Carroll G
Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
[TBL] [Abstract][Full Text] [Related]
31. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
[TBL] [Abstract][Full Text] [Related]
32. The crystal structure of murine leukemia inhibitory factor.
Robinson RC; Grey LM; Staunton D; Stuart DI; Heath JK; Jones EY
Ann N Y Acad Sci; 1995 Jul; 762():179-87; discussion 187-8. PubMed ID: 7668528
[TBL] [Abstract][Full Text] [Related]
33. CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain.
Gregg C; Weiss S
Development; 2005 Feb; 132(3):565-78. PubMed ID: 15634701
[TBL] [Abstract][Full Text] [Related]
34. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
35. Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells.
Koshimizu U; Taga T; Watanabe M; Saito M; Shirayoshi Y; Kishimoto T; Nakatsuji N
Development; 1996 Apr; 122(4):1235-42. PubMed ID: 8620850
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.
Robinson RC; Grey LM; Staunton D; Vankelecom H; Vernallis AB; Moreau JF; Stuart DI; Heath JK; Jones EY
Cell; 1994 Jul; 77(7):1101-16. PubMed ID: 8020098
[TBL] [Abstract][Full Text] [Related]
37. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines.
Aasland D; Schuster B; Grötzinger J; Rose-John S; Kallen KJ
Biochemistry; 2003 May; 42(18):5244-52. PubMed ID: 12731865
[TBL] [Abstract][Full Text] [Related]
39. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
Gearing DP; Thut CJ; VandeBos T; Gimpel SD; Delaney PB; King J; Price V; Cosman D; Beckmann MP
EMBO J; 1991 Oct; 10(10):2839-48. PubMed ID: 1915266
[TBL] [Abstract][Full Text] [Related]
40. Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
Kamohara H; Ogawa M; Ishiko T; Sakamoto K; Baba H
Int J Oncol; 2007 Apr; 30(4):977-83. PubMed ID: 17332938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]